Pulse Biosciences, Inc.
Healthcare & Life Sci
Company overview
Pulse Biosciences develops and sells its nPulse technology, which uses Nanosecond Pulsed Field Ablation to treat soft tissue, mainly for cardiac rhythm disorders and benign thyroid nodules. The nPulse Vybrance Percutaneous Ablation System treats thyroid nodules, the nsPFA 360 Catheter Endocardial Ablation System is used for cardiac ablation, and CellFX nsPFA Technology is the underlying platform behind them. Pulse Biosciences, Inc is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States